CRP and COVID-19: Furthermore, the proportions of abnormal liver function tests (51.9% vs 22.2%, P < 0.0001) and elevated C-reactive protein level (90.2% vs 60.7%, P < 0.0001) were significantly higher in AOSD patients than in patients with COVID-19.